AnteoTech Limited

ASX (AUD): AnteoTech Limited (ADO)

Last Price

0.018

Today's Change

-0.002 (10.00%)

Day's Change

0.018 - 0.02

Trading Volume

3,773,672

Profile
ADO

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. David John Radford B.Sc., BSc (Hons), M.B.A., MAICD Mr. David John Radford B.Sc., BSc (Hons), M.B.A., MAICD

Full Time Employees:  24 24

IPO Date:  2000-04-06 2000-04-06

CIK: 

ISIN:  AU000000ADO8 AU000000ADO8

CUSIP:  Q0424V101 Q0424V101

Beta:  1.27 1.27

Last Dividend:  0.00 0.00

Dcf Diff:  0.03 0.03

Dcf:  -0.01 -0.01

Description

AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Address

Brisbane Technology Park,
Eight Mile Plains, QLD 4113, AU

61 7 3219 0085

http://www.anteotech.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment